Affiliations 

  • 1 School of Pharmacy, Fudan University, Shanghai, 201203, P. R. China
  • 2 State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, P. R. China
  • 3 Chemistry Department, Faculty of Science, University of Malaya, Kuala Lumpur, 50603, Malaysia
  • 4 School of Pharmacy, Lanzhou University, Lanzhou, 730000, Gansu, P. R. China
  • 5 National Center for Natural Products Research, University of Mississippi, Oxford, MS, 38677, USA
  • 6 Colleges of Pharmacy and Medicine, Medical University of South Carolina, Charleston, SC, 29425-5700, USA
Angew Chem Int Ed Engl, 2021 Oct 04;60(41):22270-22275.
PMID: 34374477 DOI: 10.1002/anie.202109082

Abstract

Forrestiacids A (1) and B (2) are a novel class of [4+2] type pentaterpenoids derived from a rearranged lanostane moiety (dienophile) and an abietane unit (diene). These unprecedented molecules were isolated using guidance by molecular ion networking (MoIN) from Pseudotsuga forrestii, an endangered member of the Asian Douglas Fir Family. The intermolecular hetero-Diels-Alder adducts feature an unusual bicyclo[2.2.2]octene ring system. Their structures were elucidated by spectroscopic analysis, GIAO NMR calculations and DP4+ probability analyses, electronic circular dichroism calculations, and X-ray diffraction analysis. This unique addition to the pentaterpene family represents the largest and the most complex molecule successfully assigned using computational approaches to predict accurately chemical shift values. Compounds 1 and 2 exhibited potent inhibitory activities (IC50 s <5 μM) of ATP-citrate lyase (ACL), a new drug target for the treatment of glycolipid metabolic disorders including hyperlipidemia. Validating this activity 1 effectively attenuated the de novo lipogenesis in HepG2 cells. These findings provide a new chemical class for developing potential therapeutic agents for ACL-related diseases with strong links to traditional medicines.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.